Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study
在一项递增单剂量首次人体研究中，评估人源抗白细胞介素-13单克隆抗体（CNTO 5825）的安全性、耐受性和药代动力学
期刊:British Journal of Clinical Pharmacology
影响因子:3.1
doi:10.1111/j.1365-2125.2012.04477.x
Bart van Hartingsveldt ,Ivo P Nnane, Esther Bouman-Thio, Matthew J Loza, Alexa Piantone, Hugh M Davis, Kevin J Petty
